Biology of Blood and Marrow Transplantation · 2019 · 17 citations · 32 references
MedicineHematologyImmunologyHematologic OncologyStem Cell TransplantationTransplant ImmunologyAllogeneic Stem Cell TransplantationConditioning RegimensDonor MatchingHematopoietic Stem Cell TransplantationHla MatchingTransplant ComplicationsAllogeneic Transplant ConditioningConditioning Regimen ToxicityHla Antigen MatchingPeripheral Blood Stem Cell InfusionPeripheral Blood Stem CellsRegimen-related ToxicityTransplantation For Hematologic MalignanciesUnrelated Donation
Conditioning with fludarabine and low-dose total-body irradiation before allogeneic hematopoietic cell transplantation (HCT) enabled treating older or medically infirm patients with advanced hematologic malignancies in the outpatient setting. Between December 1997 and June 2017, 1037 patients with hematologic malignancies received peripheral blood stem cell (PBSC) grafts from HLA-matched or 1 HLA antigen/allele-mismatched related or unrelated donors. Median age was 58 (range, 18 to 80) years. Serious comorbidities with Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) scores ≥3 were present in 52% of patients. We found that 47% of patients were either never hospitalized or only had an overnight hospital stay for infusion of late-arriving PBSCs while 53% were admitted for a median of 6 days. Main reasons for admission were infection, fever, graft-versus-host disease, and regimen-related toxicity. Two thirds of admissions occurred within 3 weeks of HCT. The 5-year risk of nonrelapse mortality (NRM) was 26% among hospitalized patients and 13% among nonhospitalized patients. Significant risk factors for hospitalization included unrelated transplants, 1 HLA antigen-mismatched transplant, high HCT-CI scores, and diagnosis of nonmyeloma malignancies. Significant risk factors for NRM were hospitalization, older age, unrelated transplants, and high HCT-CI scores. Ambulatory allogeneic HCT is feasible and safe.
32
Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.4K citations · Full text
Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic et al. · Biology of Blood and Marrow Transplantation · 2005 · 3.5K citations
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Ted Gooley, Jason W. Chien, Steven A. Pergam et al. · New England Journal of Medicine · 2010 · 1.5K citations · Full text
Medicine, Hematology, Surgery +17